In another sign that formerly illicit psychotropics are going mainstream, the Lone Star State just passed laws friendly to marijuana and magic mushrooms. Read More
Analyst Articles
Second-quarter earnings, as well as equity prices, are soaring in the energy sector. But green activists have put fossil fuel giants in a tough spot. Read More
Stocks recently swooned after the Fed unveiled a more hawkish stance, but the central bank still hasn’t indicated the start of bond purchase “tapering.” Read More
Stocks have been rallying but don’t get complacent. Inflation, an increasingly hawkish Fed, and excessive valuations pose risks. Here are protective steps. Read More
In this interview with a top analyst on our staff, we examine a range of investment topics of pressing concern to investors. Read More
As we approach the end of Q2 2021, here’s a snapshot of the first six months in the U.S. marijuana industry, with projections for the rest of the year. Read More
The pace of initial public offerings so far this year is breaking records. Here’s how to profitably play the trend, without undue risks. Read More
As Q3 looms on the horizon, here are the investment themes that are poised for the greatest growth and those that are likely to lag. Read More
The pandemic has shattered the conventional relationship between employers and workers, spawning new investment opportunities. Read More
Despite gridlock on cannabis legalization efforts in Congress, the coronavirus crisis has created conditions that are generating record sales for weed. Read More